Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain

Genes and Development

Volumn 10, Issue 5, 1996, Pages 517-527

  Li, Xiao Yong ^a   Green, Michael R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

activation domain; ATF 2; bZIP DNA binding domain; cell type specificity; transcription activator

Indexed keywords

DNA; DNA BINDING PROTEIN; HYBRID PROTEIN; LEUCINE ZIPPER PROTEIN; TRANSCRIPTION FACTOR;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CELL TYPE; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0030007235     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.5.517     Document Type: Article

References (62)

1. Abdel-Hafiz, H.A.-M., C.-y. Chen, T. Marcell, D.J. Kroll, and J.P. Hoeffler. 1992a. Structural determinants outside of the leucine zipper influence the interactions of CREB and ATF-2: Interaction of CREB with ATF-2 blocks E1a-ATF-2 complex formation. Oncogene 8: 1161-1174.
2. Abdel-Hafiz, H.A.-M., L.E. Heasley, J.M. Kyriakis, J. Avruch, D.J. Kroll, G.L. Johnson, and J.P. Hoeffler. 1992b. Activating transcription factor-2 DNA-bindmg activity is stimulated by phosphorylation catalyzed by p42 and p54 microtubule-associated protein kinase. Mol. Endocrinol. 6: 2079-2089.
3. Baeuerle, P.A. and D. Baltimore. 1988. IκB: A specific inhibitor of the NF-κB transcription factor. Science 242: 540-546.
4. Baichwal, V R. and R. Tjian. 1990. Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain δ: Differences between v- and c-Jun. Cell 63: 815-825.
5. Beg, A.A. and A.S.J. Baldwin. 1993. The IκB proteins: Multifunctional regulators of Rel/NF-κB transcription factors. Genes & Dev. 7: 2064-2070.
6. Chatton, B., J.L. Bocco, M. Gaire, C. Hauss, B. Reimund, J.Goetz, and C. Kdinger. 1993. Transcriptional activation by the adenovirus large E1a product is mediated by members of the cellular transcription factor ATF family which can directly associate with E1a. Mol. Cell Biol. 13: 561-570.
7. Courey, A. and R. Tjian. 1988. Analysis of Spl in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55: 887-898.
8. Culp, J.S., L.C. Webster, D.J. Friedman, C.L. Smith, W.J. Huang, F. Y.-H. Wu, M. Rosenberg, and R.P. Ricciardi. 1988. The 289-amino acid E1a protein of adenovirus binds zinc in a region that is important for trans-activation. Proc. Natl. Acad. Sci. 89: 2150-2154.
9. Diamond, M.I., J.N. Miner, S K. Yoshinaga, and K.R. Yamamoto. 1990. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249: 1266-1272.
10. Du, W., D. Thanos, and T. Maniatis. 1993. Mechanisms of transcriptional synergism between distinct virns-inducible enhancer elements. Cell 74: 887-898.
11. Dwarki, V.J., M. Montminy, and L.M. Verma. 1990. Both the basic region and the "leucine zipper" domain of the cyclic AMP response element binding (CREB) protein are essential for transcriptional activation. EMBO J. 9: 225-232.
12. Evans, R. 1988. The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
13. Flint, J. and T. Shenk. 1989. Adenovirus E1a protein paradigm viral transactivator. Annu. Rev. Genet. 23: 141-161.
14. Foulkes, N.S., E Borrelli, and P. Sassone-Corsi. 1991. CREM gene, use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell 64: 739-749.
15. Franklin, A.A., M.K. Kubik, M.N. Uittenbogaard, A. Brauweiler, P. Utaisincharoen, M.-A H. Matthews, W.S. Dynan, J.P. Hoeffler, and J.K. Nyborg. 1993. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF2) ATF2 response and cAMP element-binding protein (CREB). J. Biol Chem. 268: 21225-21231.
16. Fujita, T., G.P. Nolan, S. Ghosh, and D. Baltimore. 1992. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB. Genes & Dev. 6: 775-787.
17. Gaire, M., B. Chatton, and C. Kedinger. 1990. Isolation and characterization of two novel, closely related ATF cDNA clones from HeLa cells. Nucleic Acids Res. 18: 3467-3473.
18. Georgopoulos, K., B.A. Morgan, and D.D. Moore. 1992. Functionally distinct isoforms of the CRE-BP DNA-bindmg protein mediate activity of a T-cell-specific enhancer. Mol Cell. Biol. 12: 747-757.
19. Gonzalez, G.A. and M. Montminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59: 675-680.
20. Gonzalez, G.A., K.K. Yamamoto, W.H. Fischer, D. Karr, P. Menzel, W.I. Biggs, W.W. Vale, and M. Montminy. 1989. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature 337: 749-752.
21. Gupta, S., D. Campbell, B. Derijard, and R.J. Davis. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267: 389-393.
22. Hai, T., F. Liu, W.J. Coukos, and M.R. Green. 1989. Transcription factor ATF cDNA clones: An extensive family of leucine zipper protcins able to selectively form DNA-binding heterodimers. Genes & Dev. 3: 2083-2090.
23. Helm, K. and E. Harlow 1993. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol. 3: 43-46.
24. Hill, C.S., J. Wynne, and R. Treisman. 1994. Serum-regulated transcription by serum response factor (SRF): A novel role for the DNA binding domain. EMBO J. 13: 5421-5432.
25. Hoeffler, J.P., T.E. Meyer, Y. Yun, J.L. Jameson, and J.F. Habener. 1988. Cyclic-AMP-responsive DNA-binding protein: Structure based on a cloned placental cDNA. Science 242: 1430-1433.
26. Ivashkiv, L.B., M.D. Fleming, and L.H. Glimcher. 1992. Dominant negative mutants of transcription factor mXBP (CREBP1, ATF2). New Biol. 4: 360-368.
27. Johansen, F.-E. and R. Prywes. 1993. Identification of transcriptional activation and inhibitory domains in serum response factor (SRF) by using GAL4-SRF constructs. Mol Cell. Biol. 13: 4640-4647.
28. Johnson, F.F. and S.L. McKnight. 1989. Eukaryotic transcriptional regulatory proteins. Annu. Rev. Biochem. 58: 799-839.
29. Jonat, C., H.J. Rahmsdorf, K.-K. Park, A.C.B. Cato, S. Gebel, H Ponta, and P. Herrlich. 1990. Antitumor promotion and antunflammation: down-modulation of AP-1 (Fos/Jun) activity by glutocorticoid hormone. Cell 62: 1189-1204.
30. Karin, M. and T. Hunter. 1995. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 5: 747-757.
31. Kim, S.-J, S. Wagner, F. Liu, M.A. O'Reilly, P.D. Robbins, and M.R. Green. 1992. Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF2. Nature 358: 331-334.
32. Lefstin, J. A., J.R. Thomas, and K.R. Yamamoto. 1994. Influence of a steriod receptor DNA-binding domain on transcriptional regulatory functions. Genes & Dev. 8: 2842-2856.
33. Lillie, J.W. and M.R. Green. 1989. Transcriptional activation by the adenovirus E1a protein. Nature 338: 39-44.
34. Lin, Y.-S. and M.R. Green. 1991. Mechanism of activation of an acidic transcriptional activator in vitro. Cell 64: 971-981.
35. Liu, F. and M.R. Green. 1990. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell 67: 1217-1224.
36. _. 1994. Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature 368: 520-525.
37. Livingstone, C, G. Patel, and N. Jones. 1995. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14: 1785-1797.
38. Maekawa, T., S. Matsuda, J.I. Fujisawa, M. Yoshida, and S. Ishii. 1989. Leucine zipper structure of the protein CRE-BP1 binding to the cyclic-AMP responsive element in brain. EMBO J. 8: 2023-2028.
39. Maekawa, T., S. Matsuda, J.I. Fujisawa, M. Yoshida, and S. Ishii. 1991. Cyclic-AMP-response element binding protein, CREBP1, mediates the E1a-induced but not the Tax-induced trans-activation. Oncogene 6: 627-632.
40. Maguire, H.F., J.P. Hoefflcr, and A. Siddiqui. 1991. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252: 842-844.
41. Martin, K. and M.R. Green. 1992. Transcriptional activation by viral immediate-early proteins: variations on a common theme. In Transcriptional regulation (ed, S.L. McKnight and K.R. Yamamoto), pp. 695-725. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
42. Moman, J., G.P. Zambetti, D.C. Olson, D. George, and A. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
43. Monmoto, R. 1993. Cells in stress: transcriptional activation of heat shock genes. Science 259: 1409-1410.
44. O'Hare, P. 1993. The virion transactivator of herpes simplex virus. In The alpha-herpesviruses (ed. A.J. Davison), pp. 145-155. Saunders Scientific Publications, Philadelphia, PA.
45. O'Shea, E.K., R. Rutkowski, W.F. Stafford III, and P.S. Kim. 1989. Preferential heterodimer formation by isolated leucine zippers from Fos and Jun. Science 254: 539-544.
46. Picard, D. and K.R. Yamamoto. 1987. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 6: 3333-3340.
47. Ptashne M. 1988. How eukaryotic transcriptional activators work. Nature 335: 683-689.
48. Sadowski, I. and M. Ptashne. 1989. A vector for expressing GAL4(1-147) fusion in mamaliam cells. Nucleic Acids Res. 17: 7539.
49. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
50. Semmes, O.J. and K.-T. Jeang. 1992. HTLV-I Tax is a zinc binding protein: Role for zinc in Tax structure and function. Virology 188: 754-764.
51. Smith, D.B. and K.S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67: 31-40.
52. Southgate, C.D. and M.R. Green. 1995. Delineating minimal protein domains and promoter elements for transcriptional activation by lentivirus Tat proteins. J. Virol. 69: 2605-2610.
53. Thompson, C.C. and S.L. McKnight. 1992. Anatomy of an enhancer. Trends Genet. 8: 232-236.
54. Triezenberg, S.J. 1995. Structure and function of transcriptional activation domains. Curr. Opin. Genet. Dev. 5: 190-196.
55. Triezenberg S.J., R.C. Kingsbury, and S.L. McKnight. 1988. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes &. Dev. 2: 718-729.
56. van Dam, H., D. Wilhelm, I. Herr, A. Steffen, P. Herrlich, and P. Angel. 1995. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14: 1798-1811.
57. Wagner, S. and M.R. Green. 1993. HTLV-1 Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262: 395-399.
58. Walker, S., S. Hayes, and P. O'Hare. 1994. Site-specific conformational alteration of the Oct-1 POU domain-DNA complex as the basis for differential recognition by Vmw65(VP16). Cell 79: 841-852.
59. Whiteside, S.T. and S. Goodbourn. 1993. Signal transduction and nuclear targeting: Regulation of transcription factor activity by subcellular localization. J. Cell Sci. 104: 949-955.
60. Wigler, M., A. Pellicer, S. Silverstein, and P. Axel. 1978. Biochemical transfer of single-copy eukaryotic genes using total cellular DNA as donor. Cell 14: 725-731.
61. Yoshimura, T., J.-I. Fujisawa, and M. Yoshida. 1990. Multiple cDNA clones encoding nuclear proteins that bind to the taxdependent enhancer of HTLV-1 : All contain a leucine zipper structure and basic amino acid domain. EMBO J. 9: 2537-2542.
62. Zu, Y.-L. T. Maekawa, S. Matsuda, and S. Ishii. 1991. Complete putative metal finger and leucine zipper structures of CREBP 1 arc required for the E1a-induced trans-activation. J. Biol. Chem. 266: 24134-24139.